标题
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-09-15
DOI
10.3389/fcimb.2022.945368
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
- (2022) John P. Thomas et al. Frontiers in Immunology
- Bile acid–gut microbiota crosstalk in irritable bowel syndrome
- (2022) Yu Gu et al. CRITICAL REVIEWS IN MICROBIOLOGY
- The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases
- (2022) Zengliang Jiang et al. Nature Communications
- How do intestinal probiotics restore the intestinal barrier?
- (2022) Hong-Zhong Gou et al. Frontiers in Microbiology
- Alterations in Bile Acid Metabolism Associated With Inflammatory Bowel Disease
- (2021) Na Li et al. INFLAMMATORY BOWEL DISEASES
- The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model
- (2021) Philipp Schwabl et al. Biomedicines
- Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease
- (2021) Chao Sang et al. JOURNAL OF PROTEOME RESEARCH
- Bile acids and their receptors in metabolic disorders
- (2021) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis
- (2021) Guoxiang Xie et al. EBioMedicine
- Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
- (2021) Min Yang et al. Nutrients
- Review: microbial transformations of human bile acids
- (2021) Douglas V. Guzior et al. Microbiome
- Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review
- (2021) Jun-Jie Hou et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis
- (2021) Xiaoyong Xue et al. Chinese Medicine
- Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease
- (2021) Li-Hong He et al. Frontiers in Microbiology
- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
- (2020) John Y. L. Chiang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Modulation of bile acid profile by gut microbiota in chronic hepatitis B
- (2020) Xiaolin Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Total bile acid-to-cholesterol ratio as a novel noninvasive marker for significant liver fibrosis and cirrhosis in patients with non-cholestatic chronic hepatitis B virus infection
- (2020) Li-Ting Yan et al. MEDICINE
- Comprehensive amelioration of high-fat diet-induced metabolic dysfunctions through activation of the PGC-1α pathway by probiotics treatment in mice
- (2020) Jeonghyeon Kwon et al. PLoS One
- A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD
- (2020) Tien S. Dong et al. Scientific Reports
- Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis
- (2020) Simon Hohenester et al. Cells
- A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature
- (2020) Mauro Giuffrè et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Prior Toxoplasma Gondii Infection Ameliorates Liver Fibrosis Induced by Schistosoma Japonicum through Inhibiting Th2 Response and Improving Balance of Intestinal Flora in Mice
- (2020) Fei Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bile acids associate with specific gut microbiota, low‐level alcohol consumption and liver fibrosis in patients with non‐alcoholic fatty liver disease
- (2020) Leon A. Adams et al. LIVER INTERNATIONAL
- A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
- (2020) Meilin Wei et al. EBioMedicine
- Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
- (2020) Natascha Roehlen et al. Cells
- Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection
- (2020) Guoxiang Xie et al. BMC Medicine
- Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
- (2020) Daniel M. Chopyk et al. GASTROENTEROLOGY
- A metabolic pathway for bile acid dehydroxylation by the gut microbiome
- (2020) Masanori Funabashi et al. NATURE
- Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
- (2020) Lei Hou et al. Frontiers in Immunology
- Mucus barrier, mucins and gut microbiota: the expected slimy partners?
- (2020) Paola Paone et al. GUT
- Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
- (2020) Giljae Lee et al. Nature Communications
- The gut microbiome-bile acid axis in hepatocarcinogenesis
- (2020) Liwei Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- The Role of the Gut Microbiome in Liver Cirrhosis Treatment
- (2020) Na Young Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Primary biliary cholangitis
- (2020) Ana Lleo et al. LANCET
- Gut microbiota mediated molecular events and therapy in liver diseases
- (2020) Xiaoqiang Qi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The role of the gut microbiome and its metabolites in metabolic diseases
- (2020) Jiayu Wu et al. Protein & Cell
- Gut Microbiome Contributes to Liver Fibrosis Impact on T Cell Receptor Immune Repertoire
- (2020) Qing Liang et al. Frontiers in Microbiology
- Effect of nicotinamide riboside on lipid metabolism and gut microflora‐bile acid axis in alcohol‐exposed mice
- (2020) Xiao Yu et al. Food Science & Nutrition
- The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
- (2020) Erica Jennison et al. Clinical and Molecular Hepatology
- Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression
- (2020) Nisreen Nimer et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- Deficiency of both farnesoid X receptor and Takeda G protein-coupled receptor 5 exacerbated liver fibrosis in mice
- (2019) Jessica M. Ferrell et al. HEPATOLOGY
- Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease
- (2019) Ki Tae Suk et al. Expert Review of Gastroenterology & Hepatology
- Role of the intestinal microbiome in liver fibrosis development and new treatment strategies
- (2019) Rongrong Zhou et al. Translational Research
- NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
- (2019) Stephen A. Harrison et al. HEPATOLOGY
- Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis
- (2019) Weihua Chen et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Dual Role of Bile Acids on the Biliary Epithelium: Friend or Foe?
- (2019) Leonardo Baiocchi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microbiome Signatures Associated with Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease
- (2019) Jeffrey B. Schwimmer et al. GASTROENTEROLOGY
- Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome
- (2019) Xinyu Qi et al. NATURE MEDICINE
- Probiotic LGG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice
- (2019) Yunhuan Liu et al. HEPATOLOGY
- Determining the protective effects of Yin-Chen-Hao Tang against acute liver injury induced by carbon tetrachloride using 16S rRNA gene sequencing and LC/MS-based metabolomics
- (2019) Fang Liu et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study
- (2019) Ning Liu et al. Experimental and Therapeutic Medicine
- Bile acid metabolites control TH17 and Treg cell differentiation
- (2019) Saiyu Hang et al. NATURE
- Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis
- (2019) Jin Chen et al. Obesity
- Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice
- (2019) Si-Zhe Wan et al. Frontiers in Pharmacology
- The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression
- (2019) Dishen Chen et al. Cells
- The relationship between fecal bile acids and microbiome community structure in pediatric Crohn’s disease
- (2019) Jessica Connors et al. ISME Journal
- Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments
- (2018) Zhimin Liu et al. BMC GASTROENTEROLOGY
- Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
- (2018) Chi Ma et al. SCIENCE
- Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy
- (2018) Yanhai Feng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
- (2018) Maurizio Parola et al. MOLECULAR ASPECTS OF MEDICINE
- The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation
- (2018) Kaisa Hiippala et al. Nutrients
- The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism
- (2018) Sarah Just et al. Microbiome
- Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD
- (2018) Cyrielle Caussy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice
- (2018) Han Zheng et al. Frontiers in Physiology
- The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
- (2017) Puneet Puri et al. HEPATOLOGY
- Liver inflammation and fibrosis
- (2017) Yukinori Koyama et al. JOURNAL OF CLINICAL INVESTIGATION
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids
- (2017) Aafke W. F. Janssen et al. JOURNAL OF LIPID RESEARCH
- The Gastrointestinal Microbiome: A Review
- (2017) P.C. Barko et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Interactions between gut bacteria and bile in health and disease
- (2017) Sarah L. Long et al. MOLECULAR ASPECTS OF MEDICINE
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Regression of Liver Fibrosis
- (2017) John Iredale et al. SEMINARS IN LIVER DISEASE
- Intestinal flora imbalance promotes alcohol-induced liver fibrosis by the TGFβ/smad signaling pathway in mice
- (2017) Dong Zhang et al. Oncology Letters
- BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
- (2017) Adriana Carino et al. Scientific Reports
- From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
- (2016) Ara Koh et al. CELL
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis
- (2016) Benjamin Lelouvier et al. HEPATOLOGY
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis
- (2016) Xiaoning Wang et al. JOURNAL OF PROTEOME RESEARCH
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology
- (2016) Yanfei Chen et al. Scientific Reports
- Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?
- (2015) P. Pavlidis et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Immunosurveillance of the Liver by Intravascular Effector CD8 + T Cells
- (2015) Luca G. Guidotti et al. CELL
- Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases
- (2015) Suzanne Devkota et al. DIGESTIVE DISEASES
- Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
- (2015) Jasmohan S. Bajaj et al. HEPATOLOGY
- Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis
- (2015) Tadashi Namisaki et al. JOURNAL OF GASTROENTEROLOGY
- 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis
- (2015) Martina Sombetzki et al. JOURNAL OF HEPATOLOGY
- The vocabulary of microbiome research: a proposal
- (2015) Julian R. Marchesi et al. Microbiome
- Colonic inflammation and secondary bile acids in alcoholic cirrhosis
- (2014) Genta Kakiyama et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Interactions Between the Intestinal Microbiome and Liver Diseases
- (2014) Bernd Schnabl et al. GASTROENTEROLOGY
- Alterations of the human gut microbiome in liver cirrhosis
- (2014) Nan Qin et al. NATURE
- Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice
- (2014) Chiara Degirolamo et al. Cell Reports
- Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model
- (2013) Hirofumi Okubo et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Pleiotropic Roles of Bile Acids in Metabolism
- (2013) Thomas Q. de Aguiar Vallim et al. Cell Metabolism
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis
- (2013) Linda Hammerich et al. HEPATOLOGY
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice
- (2013) Samuele De Minicis et al. HEPATOLOGY
- Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
- (2013) Genta Kakiyama et al. JOURNAL OF HEPATOLOGY
- Altered profile of human gut microbiome is associated with cirrhosis and its complications
- (2013) Jasmohan S. Bajaj et al. JOURNAL OF HEPATOLOGY
- Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis
- (2013) Marion J. Pollheimer et al. MOLECULAR ASPECTS OF MEDICINE
- Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
- (2013) Yukihiro Furusawa et al. NATURE
- Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
- (2012) Jasmohan S. Bajaj et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
- (2012) Fanli Meng et al. GASTROENTEROLOGY
- Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice
- (2012) Bo Kong et al. HEPATOLOGY
- Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C
- (2012) A. Shlomai et al. JOURNAL OF VIRAL HEPATITIS
- Diversity, stability and resilience of the human gut microbiota
- (2012) Catherine A. Lozupone et al. NATURE
- Intestinal barrier function in health and gastrointestinal disease
- (2012) M. Camilleri et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Linkage of gut microbiome with cognition in hepatic encephalopathy
- (2011) Jasmohan S. Bajaj et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Characterization of fecal microbial communities in patients with liver cirrhosis
- (2011) Yanfei Chen et al. HEPATOLOGY
- Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes
- (2011) Elaine Studer et al. HEPATOLOGY
- Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut
- (2011) Ekihiro Seki et al. JOURNAL OF PHYSIOLOGY-LONDON
- Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D
- (2010) Daniel R. Schmidt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via Gαi-protein-coupled receptors and the AKT pathway
- (2010) Risheng Cao et al. JOURNAL OF LIPID RESEARCH
- Inflammasome-mediated regulation of hepatic stellate cells
- (2009) Azuma Watanabe et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The enterohepatic circulation of bile acids in mammals: form and functions
- (2009) Alan et al. Frontiers in Bioscience-Landmark
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search